Perioperative Cangrelor in a Lung Transplant Patient with Recent Percutaneous Coronary Intervention: A Case Report (ATC 2026) - Jun 17, 2026 - Abstract #Abstract D265; Pres time: Jun 23, 2026; 02:30 PM - 03:30 PM; Location: Exhibit Hall; "He was initiated on dual antiplatelet therapy (DAPT), with aspirin and ticagrelor, for an intended duration of 6 to 12 months...The patient was discharged from index hospitalization on postoperative day 10 on therapeutic enoxaparin and clopidogrel; aspirin was held.* To date, no published cases have described cangrelor use as bridging therapy in lung transplant. To date, no published cases have described cangrelor use as bridging therapy in lung transplant. This case demonstrates the feasibility of cangrelor as a bridging therapy in lung transplant for recipients requiring DAPT. The risk of bleeding versus thrombotic events must be carefully considered when managing antiplatelet therapy in this complex patient population."
Case report • Clinical • Cardiovascular • Coronary Artery Disease • Interstitial Lung Disease • Pulmonary Disease • Respiratory Diseases • Thrombosis • Transplantation
|
|
E. Kincaide; H. Keyt; A. Aubin; E. Sako; J. Gauthier
|